These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25676051)

  • 1. Synthetic biology and intellectual property rights: six recommendations.
    Minssen T; Rutz B; van Zimmeren E
    Biotechnol J; 2015 Feb; 10(2):236-41. PubMed ID: 25676051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual property rights, standards and data exchange in systems biology: Reflections from the IP Expert Meeting at the University of Luxembourg, 8-9 October 2015, ERASysAPP - ERA-Net for Systems Biology Applications.
    van Zimmeren E; Rutz B; Minssen T
    Biotechnol J; 2016 Dec; 11(12):1477-1480. PubMed ID: 27966844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health.
    Schneider I
    Rev Derecho Genoma Hum; 2012; (37):193-233. PubMed ID: 23520920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsibility and intellectual property in synthetic biology: A proposal for using Responsible Research and Innovation as a basic framework for intellectual property decisions in synthetic biology.
    König H; Dorado-Morales P; Porcar M
    EMBO Rep; 2015 Sep; 16(9):1055-9. PubMed ID: 26268525
    [No Abstract]   [Full Text] [Related]  

  • 5. Open source synthetic biology: problems and solutions.
    Fitzpatrick ER
    Seton Hall Law Rev; 2013 Nov; 43(4):1363-402. PubMed ID: 24308082
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic biology between challenges and risks: suggestions for a model of governance and a regulatory framework, based on fundamental rights.
    Colussi IA
    Rev Derecho Genoma Hum; 2013; (38):185-214. PubMed ID: 24340832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting justice in stem cell intellectual property.
    Regenberg A; Mathews DJ
    Regen Med; 2011 Nov; 6(6 Suppl):79-84. PubMed ID: 21999266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries.
    Andanda PA
    J Med Ethics; 2008 Mar; 34(3):171-9. PubMed ID: 18316458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intellectual property and funding: fueling Chinese synbio.
    Liao L; Lou Y; Tang X; Deng Z; Gao J
    Trends Biotechnol; 2024 Mar; 42(3):258-260. PubMed ID: 37980185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction: Access to life-saving medicines and intellectual property rights.
    Schroeder D
    Camb Q Healthc Ethics; 2011 Apr; 20(2):277-8. PubMed ID: 21435302
    [No Abstract]   [Full Text] [Related]  

  • 11. Marine biotechnologies and synthetic biology, new issues for a fair and equitable profit-sharing commercial use.
    Bloch JF; Tardieu-Guigues E
    Mar Genomics; 2014 Oct; 17():79-83. PubMed ID: 25116370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scientific Opinion on Risk Assessment of Synthetic Biology.
    Epstein MM; Vermeire T
    Trends Biotechnol; 2016 Aug; 34(8):601-603. PubMed ID: 27234301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of synthetic biology on patent law in view of of European jurisprudence].
    Bernardo Alvarez MA
    Rev Derecho Genoma Hum; 2014; (41):123-40. PubMed ID: 25845209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Realizing the potential of synthetic biology.
    Church GM; Elowitz MB; Smolke CD; Voigt CA; Weiss R
    Nat Rev Mol Cell Biol; 2014 Apr; 15(4):289-94. PubMed ID: 24622617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Defence of Artificial Life by Synthetic Biology From Ethical and Social Aspects.
    Chen Y; Yin Z; Shao Z; Xie Q
    J Coll Physicians Surg Pak; 2015 Jul; 25(7):519-24. PubMed ID: 26208557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the Non-rivalrousness of Intellectual Objects a Problem for the Moral Justification of Economic Rights to Intellectual Property?
    Varelius J
    Sci Eng Ethics; 2015 Aug; 21(4):895-906. PubMed ID: 24996913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needed: a new system of intellectual property rights.
    Thurow LC
    Harv Bus Rev; 1997; 75(5):94-103. PubMed ID: 10170334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Freedom and Responsibility in Synthetic Genomics: The Synthetic Yeast Project.
    Sliva A; Yang H; Boeke JD; Mathews DJ
    Genetics; 2015 Aug; 200(4):1021-8. PubMed ID: 26272997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECVAM's approach to intellectual property rights in the validation of alternative methods.
    Linge JP; Hartung T
    Altern Lab Anim; 2007 Aug; 35(4):441-6. PubMed ID: 17850189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic biology and the prospects for responsible innovation.
    Macnaghten P; Owen R; Jackson R
    Essays Biochem; 2016 Nov; 60(4):347-355. PubMed ID: 27903822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.